Viatris Inc. announced that Corinne Le Goff has joined the company as Chief Commercial Officer and will become a member of the company's Executive Leadership Team, effective April 15, 2024. Le Goff is an accomplished biotechnology and pharmaceutical executive with more than 25 years of experience leading and building highly successful teams globally. She is a visionary and entrepreneurial leader with a strong scientific background and experience across multiple markets and therapeutic areas.

Prior to joining Viatris, Le Goff was President and Chief Executive Officer of Imunon, a clinical-stage biotechnology company, where she led an organizational turnaround and rebranding effort. Prior to Imunon, Le Goff served as Chief Commercial Officer at Moderna, where she was responsible for building the commercial organization and key capabilities necessary to ensure global access to Moderna's COVID-19 vaccine. In addition, she spent six years of her career at Amgen where she served as President of the U.S. Business, Senior Vice President of Global Product Strategy & Commercial Innovation and as President of the Europe Region.

Le Goff earned a Pharm.D. from Paris Descartes University and a Master of Business Administration from La Sorbonne University, both in Paris.